AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12106829 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of alcohol consumption by 60%
Number of subjects: 61
Study 9926170 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 23
Study 9926170 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 23
Study 8058235 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.25 mg three times a day)
Number of subjects: 0
Study 8058235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8058235 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0
Study 2564011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA, 600 mg/day)
Number of subjects: 65
Study 2564011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 31724959 — intervention group
Group type: EXPERIMENTAL
Intervention: His bundle pacing (HBP)
Number of subjects: 0
Study 31724959 — intervention group
Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 0
Study 29596951 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg twice daily)
Number of subjects: 42
Study 29596951 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide MR (60-120 mg once daily)
Number of subjects: 42
Study 28625366 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) with commercially available balloon-expandable or self-expandable device
Number of subjects: 0
Study 28625366 — intervention group
Group type: COMPARATOR
Intervention: Historical surgical aortic valve replacement patients (control group)
Number of subjects: 0
Study 25639838 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD)
Number of subjects: 0
Study 25639838 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from Alendronate (ALN) to Teriparatide (TPTD)
Number of subjects: 0
Study 25639838 — intervention group
Group type: COMPARATOR
Intervention: Add Teriparatide (TPTD) to Alendronate (ALN)
Number of subjects: 0
Study 24056141 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive
Number of subjects: 132
Study 24056141 — intervention group
Group type: COMPARATOR
Intervention: Surgical staples
Number of subjects: 132
Study 22092732 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% 8-methoxypsoralen (8MOP) cream before NBUVB phototherapy
Number of subjects: 10
Study 22092732 — intervention group
Group type: COMPARATOR
Intervention: Narrowband ultraviolet B (NBUVB) alone
Number of subjects: 10
Study 19501777 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive information about the wine prior to tasting
Number of subjects: 0
Study 19501777 — intervention group
Group type: COMPARATOR
Intervention: Negative information about the wine prior to tasting
Number of subjects: 0
Study 19501777 — intervention group
Group type: COMPARATOR
Intervention: Information given after tasting
Number of subjects: 0
Study 16978159 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg bolus followed by 0.4 microg/kg/h infusion)
Number of subjects: 32
Study 16978159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15515511 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cuff-compression of the proximal calf (Study group)
Number of subjects: 32
Study 15515511 — intervention group
Group type: COMPARATOR
Intervention: No compression (Control group)
Number of subjects: 32
Study 10642718 — intervention group
Group type: EXPERIMENTAL
Intervention: Köper-knitted polyester graft
Number of subjects: 34
Study 10642718 — intervention group
Group type: EXPERIMENTAL
Intervention: warp-knitted polyester graft
Number of subjects: 34
Study 9503527 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosorption (IS) with perfusion of whole blood through activated charcoal containing DNA
Number of subjects: 11
Study 9503527 — intervention group
Group type: COMPARATOR
Intervention: Nonselective hemosorption (control)
Number of subjects: 11
Study 7722567 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation program
Number of subjects: 252
Study 7722567 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 252
Study 2691690 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 8
Study 2691690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 241364 — intervention group
Group type: EXPERIMENTAL
Intervention: SAS 643
Number of subjects: 0
Study 241364 — intervention group
Group type: COMPARATOR
Intervention: Flurazepam
Number of subjects: 0
Study 30759117 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina supplementation added to soya-maize-based porridge for 12 months (n = 251)
Number of subjects: 501
Study 30759117 — intervention group
Group type: COMPARATOR
Intervention: Soya-maize-based porridge for 12 months (n = 250)
Number of subjects: 501
Study 28347291 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored low-to-moderate intensity exercise with or without behaviour change techniques
Number of subjects: 600
Study 28347291 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored high intensity exercise with or without behaviour change techniques
Number of subjects: 600
Study 25190674 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg
Number of subjects: 1039
Study 23607215 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 ml/day of remaxol
Number of subjects: 141
Study 23607215 — intervention group
Group type: COMPARATOR
Intervention: Ringer solution and 10% glucose at 1:1 ratio
Number of subjects: 141
Study 20009943 — intervention group
Group type: EXPERIMENTAL
Intervention: lotrafilcon B contact lenses
Number of subjects: 54
Study 18628107 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal hand dystonia (FHD)
Number of subjects: 18
Study 18628107 — intervention group
Group type: COMPARATOR
Intervention: Control group (no known neuromuscular condition)
Number of subjects: 18
Study 15897341 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 28
Study 12621572 — intervention group
Group type: EXPERIMENTAL
Intervention: Moist Exposed Burn Ointment (MEBO) application
Number of subjects: 0
Study 12621572 — intervention group
Group type: COMPARATOR
Intervention: Topical antibiotic ointment application
Number of subjects: 0
Study 12621572 — intervention group
Group type: COMPARATOR
Intervention: No topical therapy
Number of subjects: 0
Study 10505286 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct PTCA
Number of subjects: 4000
Study 10505286 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 4000
Study 10505286 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct PTCA with coronary stenting
Number of subjects: 4000
Study 10505286 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct PTCA in cardiogenic shock
Number of subjects: 4000
Study 7697233 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine (600 mg/d)
Number of subjects: 367
Study 7697233 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX) (15 mg/kg/d of trimethoprim plus 75 mg/kg/d of sulfamethoxazole)
Number of subjects: 367
Study 7697233 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine
Number of subjects: 367
Study 7697233 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 367
Study 7697233 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine and Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 367
Study 2546484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural bacillus Calmette‐Guérin (BCG)
Number of subjects: 34
Study 2546484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 339786 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 19
Study 339786 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol
Number of subjects: 19
Study 31927698 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol
Number of subjects: 0
Study 31710304 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom exploration strategy
Number of subjects: 155
Study 31710304 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality websites
Number of subjects: 155
Study 31710304 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 155
Study 31710304 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet browsing
Number of subjects: 155
Study 31710304 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing information with physician
Number of subjects: 155
Study 28117875 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin 8% (24-hour pretreatment)
Number of subjects: 16
Study 28117875 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin 8% (1-hour pretreatment)
Number of subjects: 16
Study 28117875 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control (24-hour application)
Number of subjects: 16
Study 26003433 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy (rivaroxaban and ticagrelor)
Number of subjects: 420
Study 26003433 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (warfarin, clopidogrel, and aspirin)
Number of subjects: 420
Study 23232491 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and carboplatin with cediranib (30 mg daily)
Number of subjects: 87
Study 23232491 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine and carboplatin without cediranib
Number of subjects: 87
Study 21592058 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (acute)
Number of subjects: 20
Study 21592058 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (chronic)
Number of subjects: 20
Study 21592058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19336558 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest serum retinol concentrations
Number of subjects: 692
Study 19336558 — intervention group
Group type: COMPARATOR
Intervention: Lowest serum retinol concentrations
Number of subjects: 692
Study 16704649 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg kg(‐1) induction at weeks 0, 2 and 6 followed by maintenance every 8 weeks
Number of subjects: 378
Study 16704649 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab maintenance therapy
Number of subjects: 378
Study 16704649 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 378
Study 16704649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study 15549203 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide methods in East Germany
Number of subjects: 0
Study 15549203 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide methods in West Germany
Number of subjects: 0
Study 15549203 — intervention group
Group type: COMPARATOR
Intervention: Comparison of suicide methods between East and West Germany
Number of subjects: 0
Study 10830449 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (low-saturated-fat, low-cholesterol diet)
Number of subjects: 138
Study 10830449 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard diet)
Number of subjects: 138
Study 10830449 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 138
Study 9129564 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylnaltrexone (19.2 mg/kg)
Number of subjects: 14
Study 9129564 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine (0.05 mg/kg)
Number of subjects: 14
Study 9129564 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylnaltrexone (6.4 mg/kg)
Number of subjects: 14
Study 8399073 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐2, 9 mIU/m2/day by continuous intravenous infusion on days 1‐5, 8‐12, and 15‐19 with doxorubicin, 25 mg/m2 on day 14.
Number of subjects: 15
Study 8399073 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐2, 13.5 mIU/m2/day by continuous intravenous infusion on days 1‐5, 8‐12, and 15‐19 with doxorubicin, 25 mg/m2 on day 14.
Number of subjects: 15
Study 8399073 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐2, 18 mIU/m2/day by continuous intravenous infusion on days 1‐5 and 8‐12 with doxorubicin, 50 mg/m2 on day 7.
Number of subjects: 15
Study 8399073 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐2, 18 mIU/m2/day by continuous intravenous infusion on days 1‐5 and 8‐12 with doxorubicin, 25 mg/m2 on day 7.
Number of subjects: 15
Study 2868549 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole (Persantine)
Number of subjects: 890
Study 2868549 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus placebo
Number of subjects: 890
Study 29561248 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous administration of PPSV23 and QIV
Number of subjects: 162
Study 29561248 — intervention group
Group type: COMPARATOR
Intervention: Sequential administration of PPSV23 and QIV (control)
Number of subjects: 162
Study 27236330 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Community Engagement (SCE) interventions
Number of subjects: 234
Study 27236330 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SCE interventions)
Number of subjects: 234
Study 23983230 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component, multi-site intervention for dementia caregivers
Number of subjects: 498
Study 23983230 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 498
Study 22784926 — intervention group
Group type: EXPERIMENTAL
Intervention: Education of GPs on regional diabetes management guidelines
Number of subjects: 361
Study 22784926 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 361
Study 20584682 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotrend index monitoring
Number of subjects: 40
Study 20584682 — intervention group
Group type: COMPARATOR
Intervention: Standard hemodynamic parameters
Number of subjects: 40
Study 18666056 — intervention group
Group type: EXPERIMENTAL
Intervention: Burr-hole craniostomy
Number of subjects: 70
Study 18666056 — intervention group
Group type: COMPARATOR
Intervention: Twist drill craniostomy
Number of subjects: 70
Study 18666056 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study 15953576 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (1 g/min)
Number of subjects: 12
Study 15953576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12814997 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-carotene and retinol supplementation
Number of subjects: 18314
Study 12814997 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 18314
Study 10397411 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 inhalation for 20 minutes in panicking subjects with panic disorder
Number of subjects: 24
Study 10397411 — intervention group
Group type: COMPARATOR
Intervention: CO2 inhalation for 20 minutes in normal comparison subjects
Number of subjects: 24
Study 10397411 — intervention group
Group type: COMPARATOR
Intervention: CO2 inhalation for 20 minutes in non-panicking panic disorder patients
Number of subjects: 24
Study 8897217 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 52
Study 8897217 — intervention group
Group type: COMPARATOR
Intervention: Control group (no guided imagery)
Number of subjects: 52
Study 1801561 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-globulin treatment
Number of subjects: 143
Study 1801561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact type gamma-globulin
Number of subjects: 143
Study 1801561 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gamma-globulin or indomethacin)
Number of subjects: 143
Study 6141186 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutroline hydrochloride (1, 5, 10, 20, and 100 mg daily)
Number of subjects: 48
Study 31000774 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 55374
Study 31000774 — intervention group
Group type: COMPARATOR
Intervention: ADHD genetic liability
Number of subjects: 55374
Study 30524035 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low load free flow condition (15/0)
Number of subjects: 90
Study 30524035 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low load condition with 40% arterial occlusion pressure (15/40)
Number of subjects: 90
Study 30524035 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low load condition with 80% arterial occlusion pressure (15/80)
Number of subjects: 90
Study 30524035 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional high load condition (70/0)
Number of subjects: 90
Study 27310568 — intervention group
Group type: EXPERIMENTAL
Intervention: Affect-guided physical activity prescription
Number of subjects: 67
Study 27310568 — intervention group
Group type: COMPARATOR
Intervention: Heart rate-guided prescription
Number of subjects: 67
Study 24988515 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated drinks
Number of subjects: 14
Study 24988515 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated drinks
Number of subjects: 14
Study 22810163 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical Time Intervention (CTI)
Number of subjects: 150
Study 22810163 — intervention group
Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 150
Study 19138702 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine infusion
Number of subjects: 0
Study 19138702 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 0
Study 17974109 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemically modified SLA surface implants
Number of subjects: 31
Study 17974109 — intervention group
Group type: COMPARATOR
Intervention: Standard SLA surface implants
Number of subjects: 31
Study 15472817 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 50 mg per day
Number of subjects: 245
Study 15472817 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 100 mg per day
Number of subjects: 245
Study 15472817 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 150 mg per day
Number of subjects: 245
Study 15472817 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 200 mg per day
Number of subjects: 245
Study 11743140 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index carbohydrate diet (30% fat)
Number of subjects: 9
Study 11743140 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index carbohydrate diet (20% fat)
Number of subjects: 9
Study 11743140 — intervention group
Group type: COMPARATOR
Intervention: Low glycemic index carbohydrate diet (30% fat)
Number of subjects: 9
Study 11743140 — intervention group
Group type: COMPARATOR
Intervention: Low glycemic index carbohydrate diet (20% fat)
Number of subjects: 9
Study 11743140 — intervention group
Group type: COMPARATOR
Intervention: All diets during the oral glucose tolerance test (GTT)
Number of subjects: 9
Study 11743140 — intervention group
Group type: COMPARATOR
Intervention: All diets (24-hr glucose and insulin profiles)
Number of subjects: 9
Study 11743140 — intervention group
Group type: EXPERIMENTAL
Intervention: Diets A and C (area under the curve for leptin between 1230 and 2400 hr)
Number of subjects: 9
Study 9626121 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg DHEA
Number of subjects: 9
Study 9626121 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg DHEA
Number of subjects: 9
Study 9626121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 7843202 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous erythropoietin (n = 5)
Number of subjects: 21
Study 7843202 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal erythropoietin (IP1) (n = 8)
Number of subjects: 21
Study 7843202 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal erythropoietin (IP2) (n = 8)
Number of subjects: 21
Study 2979247 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg nocte
Number of subjects: 12
Study 2979247 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg b.d.
Number of subjects: 12
Study 2979247 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg b.d.
Number of subjects: 12
Study 2979247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30292875 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based daycare program (n=80)
Number of subjects: 3041
Study 26686968 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT) with medical therapy (MT)
Number of subjects: 25
Study 26686968 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (MT) alone
Number of subjects: 25
Study 26686968 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 25
Study 25291577 — intervention group
Group type: EXPERIMENTAL
Intervention: H7N9 vaccine (3.75 µg) with MF59 adjuvant
Number of subjects: 700
Study 25291577 — intervention group
Group type: COMPARATOR
Intervention: H7N9 vaccine (15 µg) with MF59 adjuvant
Number of subjects: 700
Study 25291577 — intervention group
Group type: COMPARATOR
Intervention: H7N9 vaccine (unadjuvanted)
Number of subjects: 700
Study 25291577 — intervention group
Group type: EXPERIMENTAL
Intervention: H7N9 vaccine (various doses)
Number of subjects: 700
Study 25291577 — intervention group
Group type: EXPERIMENTAL
Intervention: H7N9 vaccine (with adjuvant)
Number of subjects: 700
Study 22591968 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation
Number of subjects: 80
Study 22591968 — intervention group
Group type: COMPARATOR
Intervention: Photoselective vaporization
Number of subjects: 80
Study 20881504 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3 (0.3 g·kg‐1)
Number of subjects: 14
Study 20881504 — intervention group
Group type: COMPARATOR
Intervention: NaCl placebo (PLAC)
Number of subjects: 14
Study 18564953 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 160
Study 18564953 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturopathic Medicine (NM)
Number of subjects: 160
Study 18564953 — intervention group
Group type: COMPARATOR
Intervention: TCM
Number of subjects: 160
Study 18564953 — intervention group
Group type: COMPARATOR
Intervention: NM
Number of subjects: 160